Antiobiotic alternatives

Johan Frieling has recently been appointed as the new chief medical officer of Micreos. EPM talks to him about his experience in the pharmaceutical sector and the company’s new antibiotic alternative, Staphefekt Read more


Antiobiotic alternatives: Dutch biotech Micreos spoke at the recent RSM Medical Innovations Programme Spring Summit about the potential of endolysin technology in preventing and treating bacterial infections, even those caused by superbugs. Read more